Cargando…
Engineering an anti-CD52 antibody for enhanced deamidation stability
Deamidation evaluation and mitigation is an important aspect of therapeutic antibody developability assessment. We investigated the structure and function of the Asn-Gly deamidation in a human anti-CD52 IgG1 antibody light chain complementarity-determining region 1, and risk mitigation through prote...
Autores principales: | Qiu, Huawei, Wei, Ronnie, Jaworski, Julie, Boudanova, Ekaterina, Hughes, Heather, VanPatten, Scott, Lund, Anders, Day, Jaime, Zhou, Yanfeng, McSherry, Tracey, Pan, Clark Q., Sendak, Rebecca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748592/ https://www.ncbi.nlm.nih.gov/pubmed/31199181 http://dx.doi.org/10.1080/19420862.2019.1631117 |
Ejemplares similares
-
Engineered Fc-glycosylation switch to eliminate antibody effector function
por: Zhou, Qun, et al.
Publicado: (2020) -
Destinos : an introduction to Spanish /
por: VanPatten, Bill
Publicado: (1992) -
Antibody Fc engineering for enhanced neonatal Fc receptor binding and prolonged circulation half-life
por: Mackness, Brian C., et al.
Publicado: (2019) -
Deamidation and isomerization liability analysis of 131 clinical-stage antibodies
por: Lu, Xiaojun, et al.
Publicado: (2018) -
Deamidation alters interactions of β-crystallins in hetero-oligomers
por: Takata, Takumi, et al.
Publicado: (2009)